Skip to main content

Advertisement

SpringerLink
Log in

Drug compliance in patients with systemic scleroderma

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Although drug compliance is a crucial component of treatment effectiveness in chronic diseases, it has never been evaluated in patients with systemic scleroderma. Therefore, the aim of this descriptive study was to determine the drug compliance rate in systemic scleroderma patients and to identify risk factors for noncompliance in these patients. A cross-sectional observational study was conducted. All patients with systemic scleroderma (n = 41) who visited a rheumatic center and signed an informed consent form were included. Data were obtained during structured interviews with patients and from medical records. The Compliance Questionnaire Rheumatology (CQR) was used to determine patient compliance. The relationships between compliance rate and demographic and clinical characteristics were examined. The mean CQR score was 75 %. Based on a dichotomous rating, only 42 % of the patients achieved a satisfactory compliance rate (≥80 %). No relationships between various demographic and clinical characteristics and CQR score expressed as continuous or dichotomous variables were found. This study represents the first evaluation of drug compliance in patients with systemic scleroderma. Many noncompliant patients were identified, but no common risk factors for noncompliance were discovered. The reasons for noncompliance seem to depend on the personal features of the patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, De Keyser F (2012) Work participation and work transition in patients with systemic sclerosis: a cross-sectional study. Rheumatology 51:297–304

    Article  PubMed  Google Scholar 

  2. Nguyen C, Poiraudeau S, Mestre-Stanislas C et al (2010) Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatology 49:1–8

    Article  Google Scholar 

  3. Kowal-Bielecka O, Landewé R, Avouac J et al (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 68:620–628

    Article  PubMed  CAS  Google Scholar 

  4. Sabaté E (ed) (2003) Adherence to long-term therapies: Evidence for action. World Health Organization, Geneva

    Google Scholar 

  5. Pyne D, Chaabo K (2007) Adherence to immunosuppressant drugs in patients with connective tissue diseases [letter]. Rheumatology 46(12):1859

    Article  PubMed  CAS  Google Scholar 

  6. Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M et al (2008) Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 27(7):883–889

    Article  PubMed  Google Scholar 

  7. van den Bemt BJ, van den Hoogen FH, Benraad B, Hekster YA, van Riel PL, van Lankveld W (2009) Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. J Rheumatol 36:2164–2170

    Article  PubMed  Google Scholar 

  8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590

    Article  Google Scholar 

  9. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145

    Article  PubMed  CAS  Google Scholar 

  10. Ostojić P, Damjanov N (2006) The scleroderma assessment questionnaire (SAQ). Z Rheumatol 65:168–175

    Article  PubMed  Google Scholar 

  11. Silman A, Akesson A, Newman J et al (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83

    PubMed  CAS  Google Scholar 

  12. Ware JE Jr, Sherbourne CD (1992) The MOS 36 item Short-form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  PubMed  Google Scholar 

  13. Ware J, Kosinski M, Dewey J (2000) How to score version two of the SF-36 Health Survey. QualityMetric, Lincoln

    Google Scholar 

  14. de Klerk E, van der Heijde D, van der Tempel H, van der Linden S (1999) Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. J Rheumatol 26:2635–2641

    PubMed  Google Scholar 

  15. Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186–3191

    Article  PubMed  CAS  Google Scholar 

  16. de Klerk E, van der Heijde D, Landewé R, van der Tempel H, van der Linden S (2003) The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study. J Rheumatol 30:2469–2475

    PubMed  Google Scholar 

  17. Streiner DL, Norman GR (1989) Health measurement scales. Oxford University Press, Oxford, p 175

    Google Scholar 

  18. Derk CT, Huaman G, Jimenez SA (2008) A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset. Brit J Dermatol 158:1063–1068

    Article  CAS  Google Scholar 

  19. Hunzelmann N, Moinzadeh P, Genth E et al (2009) High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Arthritis Res Ther 11(2):R30. doi:10.1186/ar2634

    Article  PubMed  Google Scholar 

  20. Pope JE, Ouimet JM, Krizova A (2006) Scleroderma treatment differs between experts and general rheumatologists. Arthrit Care Res 55(1):138–145

    Article  Google Scholar 

  21. Meier FMP, Frommer KW, Dinser R et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. doi:10.1136/annrheumdis-2011-200742

  22. Denton CP, Krieg T, Guillevin L et al (2012) Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry. Ann Rheum Dis 71:718–721

    Article  PubMed  Google Scholar 

  23. Harrold LR, Andrade SE (2009) Medication adherence of patients with selected rheumatic conditions: a systematic review of the literature. Semin Arthritis Rheum 38(5):396–402

    Article  PubMed  Google Scholar 

  24. Vermeire E, Hearnshaw H, Van Royen P et al (2001) Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26(5):331–342

    Article  PubMed  CAS  Google Scholar 

  25. Neame R, Hammond A (2005) Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. Rheumatology 44:762–767

    Article  PubMed  CAS  Google Scholar 

  26. Sultan N, Pope JE, Clements PJ, Scleroderma Trials Study Group (2004) The Health Assessment Questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma. Rheumatology 43(4):472–478

    Article  PubMed  CAS  Google Scholar 

  27. Pope JE, Bellamy N (1995) Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials. Clin Invest Med 18(1):1–10

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant from Charles University in Prague (SVV 265 005).

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University in Prague, Heyrovskeho 1203, Hradec Kralove, 500 05, Czech Republic

    Lucie Hromadkova & Jiri Vlcek

  2. 2nd Department of Internal Medicine, University Hospital and Faculty of Medicine, Charles University in Prague, Sokolska 581, Hradec Kralove, 500 05, Czech Republic

    Tomas Soukup

  3. Computer Technology Centre, Faculty of Medicine, Charles University in Prague, Šimkova 870, Hradec Kralove, 500 38, Czech Republic

    Eva Cermakova

Authors
  1. Lucie Hromadkova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomas Soukup
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eva Cermakova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jiri Vlcek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lucie Hromadkova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hromadkova, L., Soukup, T., Cermakova, E. et al. Drug compliance in patients with systemic scleroderma. Clin Rheumatol 31, 1577–1583 (2012). https://doi.org/10.1007/s10067-012-2050-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-2050-0

Keywords

Search

Navigation